Add to My Stocks
$1.99 $0.01 (0.5%) AKTX stock closing price Jun 22, 2018 (Closing)
Prev Close* : $2
Market Cap:
Day Low: $1.97
52 Week Low: $1.70
Open: $2
Volume: -
Day High: $2.07
52 Week High: $11.95

Latest Stock Market News

Latest Articles

AKARI THERAPTC News - From Partners

AKTX Stockcharts

View AKTX PE ratio, PS ratio stocks charts and compare with peers.
AKTX Chart
Note: Compare AKARI THERAPTC stock price history with the index and industry peers.


PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio


(return on equity)

AKARI THERAPTC Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

AKTX Industry Peers

Company Price Change (%)
Titan Pharma (TTNP)1.040.05 (4.59%)
Vical (VICL)1.290.04 (3.2%)
Flex Pharma (FLKS)1.160.04 (3.57%)
Chemocentryx (CCXI)12.030.53 (4.61%)
Receptos (RCPT)231.960.03 (0.01%)
Emergent Biosolutions (EBS)51.90.43 (0.82%)
Ambit Biosciences (AMBI)15.60 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Nymox Pharmaceutical (NYMX)3.890.64 (19.69%)
Vital Therapies (VTL)6.50.7 (12.07%)
AVID BIOSERVICS (CDMO)3.530.26 (7.95%)
MiMedx (MDXG)5.980.39 (6.98%)
BioDelivery Sciences (BDSI)3.10.2 (6.9%)
Arbutus Biopharma (ABUS)6.80.43 (6.75%)
Sorrento Therapeutics (SRNE)6.550.4 (6.5%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018
CompanyPriceChange (%)
Bluebird Bio (BLUE)168.918.45 (9.85%)
Uniquire (QURE)36.183.32 (8.41%)
GTx (GTXI)17.31.19 (6.44%)
Sarepta Therapeutics (SRPT)140.339.32 (6.23%)
Amicus Therapeutics (FOLD)15.810.7 (4.24%)
Amarin (AMRN)2.880.12 (4%)
Compugen (CGEN)3.650.15 (3.95%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018

Akari Therapeutics PLC (ADR) Stock News - Partner Headlines

AKARI THERAPTC Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-32.57M-18.14M-45.31M-9.64M-3.62M
Total Operating Expense34.95M27.24M30.57M10.17M3.6M
View AKARI THERAPTC income statement
balance sheet20172016201520142013
Total Assets29.05M45.87M69.89M6.48M7.83M
Total Liabilities9.07M11.77M21.17M1.62M2.01M
Shareholders Equity19.97M34.1M48.71M4.85M5.81M
View AKARI THERAPTC balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.45M4.67M--1.88M2.03M
Net Cash from (used by) Operating Activities-24.62M-4.96M-9.46M-5.45M-2.13M
Increase (Decrease) in Prop Plant And Equipment-0.05M-0.01M-0.05M--
View AKARI THERAPTC cash flow statement

AKARI THERAPTC Stock Message Board

As of last trading day, AKARI THERAPTC stock price was $1.99. Looking at AKARI THERAPTC market capitalization, which currently stands at $23.44M, we can say that AKTX stock is a Nano Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing AKARI THERAPTC stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that AKARI THERAPTC is worth a lot, it will most likely be reflected in an inflated AKARI THERAPTC stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 42,897 shares were traded with a closing stock price of $1.99 as of Jun 22, 2018, as can be seen from AKARI THERAPTC stock quote. One can view AKARI THERAPTC stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. AKARI THERAPTC does not pay dividends. AKARI THERAPTC stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.